157 related articles for article (PubMed ID: 21352252)
1. Colorectal cancer-derived Foxp3(+) IL-17(+) T cells suppress tumour-specific CD8+ T cells.
Ma C; Dong X
Scand J Immunol; 2011 Jul; 74(1):47-51. PubMed ID: 21352252
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
3. Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer.
Yang S; Wang B; Guan C; Wu B; Cai C; Wang M; Zhang B; Liu T; Yang P
J Leukoc Biol; 2011 Jan; 89(1):85-91. PubMed ID: 20952660
[TBL] [Abstract][Full Text] [Related]
4. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
5. CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients.
Frisullo G; Nociti V; Iorio R; Plantone D; Patanella AK; Tonali PA; Batocchi AP
Hum Immunol; 2010 May; 71(5):437-41. PubMed ID: 20138197
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
7. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
[TBL] [Abstract][Full Text] [Related]
8. Peripheral CD4+CD8+cells are the activated T cells expressed granzyme B (GrB), Foxp3, interleukin 17 (IL-17), at higher levels in Th1/Th2 cytokines.
Xie D; Hai B; Xie X; Liu L; Ayello J; Ma X; Zhang J
Cell Immunol; 2009; 259(2):157-64. PubMed ID: 19616200
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta.
Liang H; Yi L; Wang X; Zhou C; Xu L
Scand J Immunol; 2014 Aug; 80(2):144-50. PubMed ID: 24813240
[TBL] [Abstract][Full Text] [Related]
10. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
[TBL] [Abstract][Full Text] [Related]
11. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.
Marwaha AK; Crome SQ; Panagiotopoulos C; Berg KB; Qin H; Ouyang Q; Xu L; Priatel JJ; Levings MK; Tan R
J Immunol; 2010 Oct; 185(7):3814-8. PubMed ID: 20810982
[TBL] [Abstract][Full Text] [Related]
13. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells.
Heimann M; Janda J; Sigurdardottir OG; Svansson V; Klukowska J; von Tscharner C; Doherr M; Broström H; Andersson LS; Einarsson S; Marti E; Torsteinsdottir S
Vet Immunol Immunopathol; 2011 Mar; 140(1-2):63-74. PubMed ID: 21168921
[TBL] [Abstract][Full Text] [Related]
14. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
15. Detection of Foxp3 protein expression in porcine T lymphocytes.
Käser T; Gerner W; Hammer SE; Patzl M; Saalmüller A
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):92-101. PubMed ID: 18565594
[TBL] [Abstract][Full Text] [Related]
16. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
17. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
18. CD8+ suppressor T cells resurrected.
Kapp JA; Bucy RP
Hum Immunol; 2008 Nov; 69(11):715-20. PubMed ID: 18817830
[TBL] [Abstract][Full Text] [Related]
19. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
Tsai YG; Yang KD; Niu DM; Chien JW; Lin CY
J Immunol; 2010 Jun; 184(12):7229-37. PubMed ID: 20483759
[TBL] [Abstract][Full Text] [Related]
20. Localization of IL-17+Foxp3+ T cells in esophageal cancer.
Huang C; Fu ZX
Immunol Invest; 2011; 40(4):400-12. PubMed ID: 21314287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]